Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib versus Novafen after impacted mandibular third molar surgery
IRCT20250109064327N1Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of celecoxib and acetaminophen + ibuprofen in postoperative pain (2 arms), sponsored by Islamic Azad University. Primary endpoints: Pain and Swelling. Started Jan 2025; status: completed.
02
Drugs
celecoxibacetaminophen + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20250109064327N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250109064327N1.